HighTower Advisors Portfolio holdings
AUM
$79.8B
1-Year Return
17.44%
This Quarter Return
+6.17%
1 Year Return
+17.44%
3 Year Return
+65.6%
5 Year Return
+120.67%
10 Year Return
+243.37%
AUM
$50.8B
AUM Growth
+$4.96B
(+11%)
Cap. Flow
+$2.41B
Cap. Flow
% of AUM
4.75%
Top 10 Holdings %
Top 10 Hldgs %
19.97%
Holding
3,426
New
282
Increased
1,691
Reduced
1,031
Closed
196
Top Buys
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$222M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$158M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$111M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$78.7M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$70.9M |
Top Sells
| 1 |
iShares Short-Term National Muni Bond ETF
SUB
|
+$60.8M |
| 2 |
IBDO
iShares iBonds Dec 2023 Term Corporate ETF
IBDO
|
+$39.4M |
| 3 |
Invesco DB US Dollar Index Bullish Fund
UUP
|
+$30.5M |
| 4 |
3M
MMM
|
+$30.3M |
| 5 |
IBDP
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
|
+$30.2M |
Sector Composition
| 1 | Technology | 14.16% |
| 2 | Financials | 10.21% |
| 3 | Healthcare | 7.63% |
| 4 | Consumer Discretionary | 6.16% |
| 5 | Industrials | 4.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Cognition Therapeutics
CGTX
$223M
| $48K | ﹤0.01% |
26,561
-2,000
| -7% | -$3.61K |
|
3102
Lineage Cell Therapeutics
LCTX
$290M
| $48K | ﹤0.01% |
34,116
-16,000
| -32% | -$22.5K |
|
3103
FuelCell Energy
FCEL
$118M
| $47K | ﹤0.01% |
730
+33
| +5% | +$2.13K |
|
|
SYRS
3104
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $47K | ﹤0.01% |
15,004
| – | – |
|
3105
Unisys
UIS
$279M
| $46K | ﹤0.01% |
+12,029
| New | +$46K |
|
3106
Innoviz Technologies
INVZ
$375M
| $45K | ﹤0.01% |
15,673
-320
| -2% | -$919 |
|
|
TGB
3107
Taseko Mines
TGB
$1.07B
| $45K | ﹤0.01% |
32,196
-20,500
| -39% | -$28.7K |
|
|
BLDP
3108
Ballard Power Systems
BLDP
$568M
| $44K | ﹤0.01% |
10,272
-1,500
| -13% | -$6.43K |
|
3109
Aurora
AUR
$10.5B
| $43K | ﹤0.01% |
14,838
+4,750
| +47% | +$13.8K |
|
|
MTTR
3110
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $43K | ﹤0.01% |
13,531
+1,444
| +12% | +$4.59K |
|
|
EXK
3111
Endeavour Silver
EXK
$1.71B
| $42K | ﹤0.01% |
14,500
-12,135
| -46% | -$35.2K |
|
3112
GrowGeneration
GRWG
$92.6M
| $42K | ﹤0.01% |
12,718
+1,485
| +13% | +$4.9K |
|
|
NGD
3113
New Gold Inc
NGD
$5.02B
| $41K | ﹤0.01% |
39,230
| – | – |
|
3114
Neurogene
NGNE
$275M
| $40K | ﹤0.01% |
2,420
| – | – |
|
3115
BioAtla
BCAB
$41.9M
| $39K | ﹤0.01% |
13,000
| – | – |
|
|
BZUN
3116
Baozun
BZUN
$223M
| $39K | ﹤0.01% |
+10,019
| New | +$39K |
|
3117
Oramed Pharmaceuticals
ORMP
$94.7M
| $39K | ﹤0.01% |
+10,500
| New | +$39K |
|
3118
SGHC Ltd
SGHC
$6.65B
| $39K | ﹤0.01% |
+13,488
| New | +$39K |
|
3119
B2Gold
BTG
$5.6B
| $38K | ﹤0.01% |
+10,554
| New | +$38K |
|
3120
Real Brokerage
REAX
$1.07B
| $38K | ﹤0.01% |
20,084
| – | – |
|
3121
Athira Pharma
ATHA
$15.1M
| $37K | ﹤0.01% |
+12,535
| New | +$37K |
|
|
HUYA
3122
Huya Inc
HUYA
$783M
| $37K | ﹤0.01% |
10,240
-100
| -1% | -$361 |
|
3123
Lisata Therapeutics
LSTA
$19.3M
| $37K | ﹤0.01% |
+10,042
| New | +$37K |
|
|
OPTN
3124
DELISTED
OptiNose
OPTN
| $37K | ﹤0.01% |
2,016
| – | – |
|
|
DMTK
3125
DELISTED
DermTech, Inc. Common Stock
DMTK
| $36K | ﹤0.01% |
13,687
+2,200
| +19% | +$5.79K |
|